Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares
(NQ:
KNSA
)
20.59
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
8
Open
20.59
Bid (Size)
18.00 (1)
Ask (Size)
29.75 (2)
Prev. Close
20.59
Today's Range
20.59 - 20.59
52wk Range
16.56 - 28.15
Shares Outstanding
71,726,685
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Exploring Kiniksa Pharmaceuticals's Earnings Expectations
October 28, 2024
Via
Benzinga
NHL Hall-of-Famer, Henrik Lundqvist, Teams Up with Kiniksa Pharmaceuticals to Launch Life DisRPted™ Campaign to Drive Awareness of Recurrent Pericarditis
October 01, 2024
– Life DisRPted is an educational campaign aimed at promoting early diagnosis and treatment of recurrent pericarditis, a painful and debilitating chronic autoinflammatory disease –
From
Kiniksa Pharmaceuticals, Ltd.
Via
GlobeNewswire
Performance
YTD
+11.12%
+11.12%
1 Month
-3.24%
-3.24%
3 Month
-16.37%
-16.37%
6 Month
+9.11%
+9.11%
1 Year
+10.70%
+10.70%
More News
Read More
KNSA Stock Earnings: Kiniksa Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024
July 23, 2024
Via
InvestorPlace
Danaher Posts Upbeat Earnings, Joins Spotify, MSCI, Owens & Minor And Other Big Stocks Moving Higher On Tuesday
July 23, 2024
Via
Benzinga
Earnings Outlook For Kiniksa Pharmaceuticals
February 27, 2024
Via
Benzinga
Earnings Outlook For Kiniksa Pharmaceuticals
October 30, 2023
Via
Benzinga
Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 23, 2024
Via
Benzinga
Sector Spotlight: Orphan Drug Developers With Significant Upside
June 03, 2024
Via
AB Newswire
Topics
ETFs
Exposures
Product Safety
Sector Spotlight: Orphan Drug Developers With Significant Upside
June 03, 2024
Via
TheNewswire.com
Topics
ETFs
Exposures
Product Safety
KNSA Stock Earnings: Kiniksa Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024
April 23, 2024
Via
InvestorPlace
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 02, 2024
Via
Benzinga
The 3 Most Undervalued Biotech Stocks to Buy in December
December 15, 2023
Via
InvestorPlace
Earnings Scheduled For April 23, 2024
April 23, 2024
Via
Benzinga
7 Underappreciated Biotech Stocks to Pick Up on the Cheap
November 09, 2023
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Amicus Therapeutics Stock Reaches 80+ Relative Strength Benchmark
September 28, 2023
Via
Investor's Business Daily
5 Value Stocks In The Healthcare Sector
September 11, 2023
Via
Benzinga
5 Value Stocks To Watch In The Healthcare Sector
August 21, 2023
Via
Benzinga
Vertex Pharmaceuticals Stock Shows Rising Relative Strength, Hits 80+
August 16, 2023
Via
Investor's Business Daily
ACELYRIN Stock Scores Relative Strength Rating Upgrade; Hits Key Threshold
August 15, 2023
Via
Investor's Business Daily
Axsome Therapeutics Stock Earns Relative Strength Rating Upgrade
August 15, 2023
Via
Investor's Business Daily
Exelixis Stock Sees Rising Relative Strength Rating
August 14, 2023
Via
Investor's Business Daily
Dynavax Technologies Stock Sees Renewed Technical Strength
August 07, 2023
Via
Investor's Business Daily
Crude Oil Up 1%; Verizon Earnings Beat Views
July 25, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
July 25, 2023
Via
Benzinga
Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 25, 2023
Via
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.